☆Avoro Capital Advisors LLC
Quality Q
0.835
AUM ($M)
11,136
Positions
26
Turnover
0.28
Top-10 wt
79%
Herfindahl
0.079
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 33 positions · portfolio value $11,136M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆UTHR funds › | UNITED THERAPEUTICS CORP | ADD | — | 13.5% | -1.8% | 1,505.1 | 2,777,777 | +147,777 | 5 | — |
| ☆ASND funds › | ASCENDIS PHARMA | NEW | — | 12.2% | +12.2% | 1,363.2 | 5,111,111 | +5,111,111 | 1 | — |
| ☆KRYS funds › | KRYSTAL BIOTECH INC | HOLD | — | 9.6% | +2.3% | 1,073.7 | 2,888,888 | +0 | 5 | — |
| ☆MDGL funds › | MADRIGAL PHARMACEUTICALS INC | ADD | — | 8.8% | -0.5% | 984.4 | 1,833,333 | +15,152 | 5 | — |
| ☆ARGX funds › | ARGENX SE | HOLD | — | 8.3% | +1.1% | 927.8 | 1,000,000 | +0 | 5 | — |
| ☆ARWR funds › | ARROWHEAD PHARMACEUTICALS INC | ADD | — | 8.3% | +1.7% | 925.6 | 11,355,555 | +655,556 | 5 | — |
| ☆KYMR funds › | KYMERA THERAPEUTICS INC | HOLD | — | 7.7% | +1.6% | 857.1 | 7,474,747 | +0 | 5 | — |
| ☆RVMD funds › | REVOLUTION MEDICINES INC | TRIM | — | 3.9% | +1.6% | 430.2 | 2,297,000 | -47,444 | 3 | — |
| ☆CYTK funds › | CYTOKINETICS INC | ADD | — | 3.8% | +1.7% | 425.9 | 4,999,999 | +1,666,666 | 2 | — |
| ☆CELC funds › | CELCUITY INC | ADD | — | 3.2% | -0.6% | 355.7 | 3,400,000 | +25,000 | 3 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | HOLD | — | 3.2% | +0.0% | 351.8 | 6,555,555 | +0 | 4 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | HOLD | — | 3.1% | -0.2% | 348.7 | 5,777,777 | +0 | 5 | — |
| ☆DFTX funds › | DEFINIUM THERAPEUTICS INC | ADD | — | 3.0% | +2.1% | 338.2 | 7,188,888 | +2,188,888 | 2 | — |
| ☆QURE funds › | UNIQURE NV | ADD | — | 2.8% | +1.8% | 309.9 | 6,727,777 | +768,182 | 5 | — |
| ☆VERA funds › | VERA THERAPEUTICS INC | TRIM | — | 2.2% | -0.1% | 245.6 | 5,723,888 | -165,000 | 5 | — |
| ☆TSHA funds › | TAYSHA GENE THERAPIES INC | ADD | — | 1.5% | +0.5% | 162.7 | 23,888,888 | +2,188,888 | 5 | — |
| ☆OCUL funds › | OCULAR THERAPEUTIX INC | ADD | — | 1.1% | +0.1% | 123.1 | 12,540,000 | +225,000 | 5 | — |
| ☆DMRA funds › | DAMORA THERAPEUTICS INC | HOLD | — | 0.9% | -0.1% | 98.4 | 3,783,000 | +0 | 2 | — |
| ☆COAG funds › | HEMAB THERAPEUTICS HLDGS INC | NEW | — | 0.6% | +0.6% | 70.7 | 1,925,150 | +1,925,150 | 1 | — |
| ☆GHRS funds › | GH RESEARCH PLC | HOLD | — | 0.4% | +0.2% | 48.4 | 1,800,000 | +0 | 3 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | ADD | — | 0.4% | +0.1% | 45.9 | 2,500,000 | +1,000,000 | 3 | — |
| ☆SEPN funds › | SEPTERNA INC | HOLD | — | 0.4% | +0.1% | 44.8 | 1,337,500 | +0 | 5 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS | ADD | — | 0.4% | +0.2% | 43.1 | 2,333,333 | +923,333 | 2 | — |
| ☆FTH funds › | FAETH THERAPEUTICS INC | NEW | — | 0.3% | +0.3% | 36.1 | 1,444,039 | +1,444,039 | 1 | — |
| ☆WHWK funds › | WHITEHAWK THERAPEUTICS INC | HOLD | Common Stock | 0.1% | +0.0% | 13.1 | 2,849,402 | +0 | 5 | — |
| ☆LXEO funds › | LEXEO THERAPEUTICS INC | TRIM | — | 0.1% | -0.0% | 6.9 | 1,489,189 | -385,811 | 3 | — |
| ☆CUSIP:03753U106 funds › | APELLIS PHARMACEUTICALS INC | EXIT | — | 0.0% | -4.8% | 0.0 | 0 | -12,222,222 | 0 | — |
| ☆CUSIP:152309100 funds › | CENTESSA PHARMACEUTICALS PLC | EXIT | — | 0.0% | -4.5% | 0.0 | 0 | -11,430,455 | 0 | — |
| ☆MNKD funds › | MANNKIND CORP | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -2,200,000 | 0 | — |
| ☆CUSIP:834203309 funds › | SOLENO THERAPEUTICS INC | EXIT | — | 0.0% | -0.8% | 0.0 | 0 | -2,300,000 | 0 | — |
| ☆CUSIP:880881107 funds › | TERNS PHARMACEUTICALS INC | EXIT | — | 0.0% | -3.0% | 0.0 | 0 | -5,695,000 | 0 | — |
| ☆CUSIP:04351P101 funds › | ASCENDIS PHARMA | EXIT | — | 0.0% | -11.4% | 0.0 | 0 | -5,062,500 | 0 | — |
| ☆ALKS funds › | ALKERMES PLC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -1,200,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 11,136 | 26 | 0.28 | 79% | 0.079 | 0.833 | — | in |
| 2026Q1 | 10,151 | 30 | 0.17 | 77% | 0.075 | 0.925 | — | in |
| 2025Q4 | 10,174 | 33 | 0.21 | 73% | 0.068 | 0.858 | — | in |
| 2025Q3 | 7,730 | 30 | 0.13 | 72% | 0.070 | 0.903 | — | in |
| 2025Q2 | 5,710 | 30 | 0.14 | 74% | 0.077 | 0.900 | — | entered |
| 2025Q1 | 6,407 | 33 | 0.00 | 74% | 0.075 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status